Thank you, Chris, and good morning, everyone. The first quarter was marked by the longest government shutdown in our nation's ...
Get live updates and the latest news as Pam Bondi faces questions from Congress about the Epstein files and Trump meets with ...
There's so much more to Barcelona's nightlife scene than the big thumping clubs. There's everything from sophisticated ...
Texas counties are moving to meet a December 1 deadline under a new Texas law that forces sheriffs into formal agreements ...
BorgWarner's battery management system (BMS) has been selected for an expanded series-production program with a global ...
Q4 2025 Earnings Call February 10, 2026 4:30 PM ESTCompany ParticipantsLeslie Green - Investor ContactJitendra Mohan - ...
Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook
Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet need, today issued a letter to ...
Q1 2026 Earnings Call February 10, 2026 8:30 AM ESTCompany ParticipantsJames Barber - CEO, President & DirectorAdam Bowen ...
We asked a sampling of industry engineers and users for their perspectives on the evolution of codec designs and applications ...
Government sources and advocates for migrant children worry the administration is concentrating pregnant unaccompanied minors ...
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
A 20-year study found brain games that boost speed and split attention helped prevent Alzheimer’s and other dementias.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results